跳至主要内容
临床试验/NCT00750906
NCT00750906终止不适用

The Muscle Biochemical, Serum Potassium and Cardiovascular Changes After Succinylcholine in Patients Undergoing Electroconvulsive Therapy.

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
13
试验地点
1

研究概览

简要总结

This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, prospective, study in patients who will be receiving ECT as indicated and prescribed by their psychiatrist. The study will be performed twice on each patient, 48-72 hours apart during consecutively scheduled ECT procedures.

详细描述

Patients will receive the anesthetic that is traditionally given which includes appropriate doses of succinylcholine. Serum potassium and creatinine phosphokinase (CK) levels will be determined pre and post anesthesia; serum and urine myoglobin will be determined post anesthesia. Vital signs data [i.e., heart rate (arrhythmias) and arterial blood pressure] will be compared pre and post anesthesia. In addition patients will be asked about the presence of muscle pain (myalgia) 1 hour before discharge from the recovery room and the following day post ECT.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A male or non-pregnant female aged 18 years and older
  • American Society of Anesthesiologists physical status 1, 2, 3
  • Scheduled to undergo electroconvulsive therapy under general anesthesia
  • Have given written informed consent

排除标准

  • Pregnant or nursing
  • Any patient in the study investigators opinion who may not be suitable for research.

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验